Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Should Income Investors Buy This Big Pharma Stock?
12:42pm, Sunday, 21'st May 2023
Pfizer's operational revenue moved higher in the first quarter. The company's low dividend payout ratio makes it a great pick for income investors.
TipRanks reveals the top 10 health care sector analysts of the past decade
08:20am, Sunday, 21'st May 2023
TipRanks' analyst ranking service ranks the top Wall Street firms of the past decade.
Pfizer's (PFE) RSV Vaccine for Infants Gets FDA Panel Vote
12:14pm, Friday, 19'th May 2023
The FDA's decision on Pfizer's (PFE) BLA seeking approval for its RSV vaccine candidate in infants through maternal immunization is expected in August.
3 Undervalued Pharma Stocks to Buy for High Total Returns
11:27am, Friday, 19'th May 2023
Throughout financial history, equity markets have navigated bull and bear cycles. The same holds true for various sectors.
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:43am, Friday, 19'th May 2023
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
07:18am, Friday, 19'th May 2023
Pfizer Inc. NYSE: PFE continued its downward trajectory on May 17, following news that the Federal Trade Commission is seeking to block Amgen Inc.'s NASDAQ: AMGN planned acquisition of Horizon Therape
RSV Vaccine: FDA Advisors Recommend Pfizer Shot To Protect Infants From Infection—Here's What To Know
07:46pm, Thursday, 18'th May 2023
The vaccine is given to pregnant people to protect infants from RSV in their first months of life.
FDA panel votes on Pfizer RSV vaccine following efficacy data
06:49pm, Thursday, 18'th May 2023
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb Yahoo Finance health care reporter Anjalee Khemlani breaks down what to know about Pfizer's RSV vaccine and the FDA Advisory panel's vote. About Yah
U.S. FDA panel backs Pfizer's RSV vaccine for protecting infants
05:04pm, Thursday, 18'th May 2023
Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc's experimental respiratory syncytial virus (RSV) vaccine, boosting its chances of becomi
FDA advisers vote in favor of Pfizer maternal RSV vaccine
05:00pm, Thursday, 18'th May 2023
Advisers to the U.S. Food and Drug Administration voted Thursday in favor of Pfizer's respiratory syncytial virus vaccine for pregnant people. FDA advisory committee votes are not binding, but the age
FDA advisors recommend Pfizer's RSV vaccine for infants but raise safety concerns
04:52pm, Thursday, 18'th May 2023
The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall.
RSV Vaccine: Here's What To Know As FDA Advisors Consider Approving Pfizer's Shot
08:31am, Thursday, 18'th May 2023
FDA analysts have flagged concerns over the risk of preterm birth for the shot, which is given to pregnant people to protect infants from RSV in their first months of life.
Charles Schwab raises $2.5 bln in bond offering amid surge in corporate bond deals
07:25am, Thursday, 18'th May 2023
Charles Schwab Corp. SCHW, +3.45% on Thursday disclosed plans for a $2.5 billion bond offering as the corporate bond market continues to pick up steam.
US FDA advisers to discuss Pfizer's maternal RSV vaccine
07:03am, Thursday, 18'th May 2023
Advisers to the U.S. Food and Drug Administration on Thursday will discuss Pfizer Inc's experimental respiratory syncytial virus (RSV) vaccine intended to protect infants through six months of age whe
Pfizer: A Lackluster Valuation And Soft Growth Outlook Despite Strong Free Cash Flow
11:59pm, Wednesday, 17'th May 2023
Pfizer has been among the worst-performing S&P 500 stocks this year as investors shun the free-cash-flow factor. With a low earnings multiple and high dividend yield, there are some positive aspects.
